GBGB9818467.4A
GB9818467D0
(en)
|
1998-08-25 |
1998-08-25 |
Organic compounds
|
AT99942911T
ATE238044T1
(en)
|
1998-08-25 |
1999-08-24 |
USE OF SUBSTANCE PANTAGONISTS TO TREAT CHRONIC FATIGUE SYNDROME AND/OR FIBROMYALGIA
|
CN99810017XA
CN1216598C
(en)
|
1998-08-25 |
1999-08-24 |
Pharmaceutical use
|
PT99942911T
PT1107744E
(en)
|
1998-08-25 |
1999-08-24 |
USE OF ANTAGONISTS OF THE P-SUBSTANCE FOR THE TREATMENT OF CHRONIC FAILURE SYNDROME AND / OR FIBROMYALGIA
|
AU56245/99A
AU5624599A
(en)
|
1998-08-25 |
1999-08-24 |
Pharmaceutical uses
|
SI9930311T
SI1107744T1
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia
|
JP2000565867A
JP4510290B2
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance P antagonist for the treatment of chronic fatigue syndrome and / or fibromyalgia and use of NK-1 receptor antagonist for the treatment of chronic fatigue syndrome
|
DK99942911T
DK1107744T3
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance P antagonists in the treatment of chronic fatigue syndrome and / or fibromyalgia
|
PCT/EP1999/006215
WO2000010545A2
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
|
DE69907220T
DE69907220T2
(en)
|
1998-08-25 |
1999-08-24 |
USE OF SUBSTANCE P ANTAGONISTS FOR TREATING CHRONIC FATIGUE SYNDROME AND / OR FIBROMYALGIA
|
CA002339628A
CA2339628C
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
|
ES99942911T
ES2198948T3
(en)
|
1998-08-25 |
1999-08-24 |
USES OF ANTAGONISTS OF SUBSTANCE P FOR THE TREATMENT OF THE CHRONIC FATIGUE SYNDROME AND / OR FIBROMIALGIA.
|
BR9913201-0A
BR9913201A
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance p antagonist for the treatment of chronic fatigue syndrome and / or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
|
EP99942911A
EP1107744B1
(en)
|
1998-08-25 |
1999-08-24 |
Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia
|
TW094103860A
TW200529847A
(en)
|
1998-08-25 |
1999-08-31 |
Pharmaceutical composition for use in the treatment of chronic fatigue syndrome or fibromyalgia or associated functional symptoms of fibromyalgia
|
US10/222,060
US20030092735A1
(en)
|
1998-08-25 |
2002-08-16 |
Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome
|
US10/947,967
US20050096334A1
(en)
|
1998-08-25 |
2004-09-23 |
Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome
|
US11/715,805
US20070155759A1
(en)
|
1998-08-25 |
2007-03-08 |
Pharmaceutical uses
|
US12/008,777
US7713984B2
(en)
|
1998-08-25 |
2008-01-14 |
Pharmaceutical uses
|
US12/618,388
US20100055176A1
(en)
|
1998-08-25 |
2009-11-13 |
Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia
|